CRDF
Cardiff Oncology, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Mani Mohindru
IPO Date
2004-07-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Cardiff Oncology, Inc.
CEO
Mani Mohindru
IPO Date
2004-07-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 0 |
| $0.00 |
| 16 Apr 2026 | Muntner Joshua B | Chief Financial Officer | Disposed | 0 | $0.00 |
| 16 Apr 2026 | Smeal Tod | Chief Scientific Officer | A-Award | Acquired | 300,000 | $1.63 |
| 16 Apr 2026 | Muntner Joshua B | Chief Financial Officer | A-Award | Acquired | 486,650 | $1.58 |
| 2 Apr 2026 | Mohindru Mani | director, officer: Chief Executive Officer | A-Award | Acquired | 600,000 | $1.62 |
| 18 Feb 2026 | Lindsay Brigitte Ute | Chief Accounting Officer | A-Award | Acquired | 200,000 | $1.60 |
| 18 Feb 2026 | Mohindru Mani | director, officer: Interim CEO | A-Award | Acquired | 200,000 | $1.56 |
| 9 Feb 2026 | Lindsay Brigitte Ute | Chief Accounting Officer | Disposed | 0 | $0.00 |
| 9 Feb 2026 | Lindsay Brigitte Ute | Chief Accounting Officer | Disposed | 90,288 | $1.72 |